0

Close
 
Upcoming Allied Market Research
2023
Protein Engineering Market

Protein Engineering Market

by Product (Instruments, Reagents, Services Software), by Technology (Rational Protein Design, Irrational Protein Design), by Protein Type (Monoclonal Antibodies, Insulin, Erythropoietin, Interferon, Colony Stimulating Factor, Growth Hormones, Coagulation Factor, Vaccines, Others) and by End User (Academic Research Institutes, Pharmaceutical Biotechnology Companies, Contract Research Organizations): Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Medical Devices & Supplies
Report Code: A00969
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Protein Engineering Market

Request Now !

Protein engineering can be defined as the modification of protein structure with recombinant DNA technology or chemical treatment to serve a desirable function and better use in medicine, industry and agriculture. Preference for protein-based drugs to non-protein-based ones along with reduced overall timeline and lower cost for drug discovery are the factors that are likely to drive the protein engineering market. High prevalence rate of lifestyle diseases along growth in funding for protein engineering. High cost of tools and instruments used in protein engineering techniques are the factors that drive the growth of the market. The demand of protein engineering developing countries coupled with preference of protein therapy over gene therapy along with the expiry of blockbuster biologics drugs in the near future. Lack of qualified researchers are the factors that offer abundant growth opportunities in the market.

The report segments the market on the basis of products, technology, protein type, end-user, and geography. On the basis of products, the report segments the market into instruments, reagents and services and software. On the basis of technology, this market is segmented into rational protein design and irrational protein design. Based on protein type, the market is segmented into monoclonal antibodies, insulin, erythropoietin, interferon, colony stimulating factor, growth hormones, coagulation factor, vaccines and others which include interleukins, follicle stimulating hormones, enzyme replacement. On the basis of end-users the market is segmented into academic research institutes, pharmaceutical & biotechnology companies and contract research organizations. On the basis of geography, the market is segmented into North America, Europe, Asia-Pacific, and Latin America, Middle East & Africa (LAMEA).
Key market players in this market are Agilent Technologies, Inc, Bio-Rad Laboratories, Inc, Bruker Corporation, Danaher Corporation, General Electric, Perkinelmer, Inc, Genscripts Usa, Inc., Sigma-Aldrich Corporation, Thermo Fisher Scientific and Waters Corporation.

KEY BENEFITS FOR STAKEHOLDERS:

  • The report provides a comprehensive analysis of current & future market trends, key market challenges and emerging avenues for the growth of this market across the globe.
  • The report offers latest technological innovations and the recent R&D developments.
  • The report offers an insight into competitive landscape in terms of new technological developments, untapped segments, and value chain analysis.
  • This report entails the detailed quantitative analysis of the current market and estimations, which assists in identifying the prevailing market opportunities.
  • The report offers detailed segmentation and analyzes the key segments in terms of market size by value and volume and country-level analysis to provide an in-depth understanding of the market.
  • Porters Five Forces analysis is offered in the report along with highlighting bargaining power of buyers and suppliers.
  • The report offers strategic analysis of financial status of key market players, and highlights market share of key vendors.
  • The report offers information on the status of new projects along with offering investment feasibility analysis of the same.

 Protein Engineering Market Report Highlights

Aspects Details
By Product
  • Instruments
  • Reagents
  • Services & Software
By Technology
  • Rational Protein Design
  • Irrational Protein Design
By Protein Type
  • Monoclonal Antibodies
  • Insulin
  • Erythropoietin
  • Interferon
  • Colony Stimulating Factor
  • Growth Hormones
  • Coagulation Factor
  • Vaccines
  • Others
By End User
  • Academic Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, UAE, Rest of LAMEA)
Key Market Players Sigma-Aldrich Corporation, Perkinelmer, Inc., Danaher Corporation, Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Thermo Fisher Scientific, Waters Corporation, General Electric, Bruker Corporation, Genscripts USA, Inc.
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: PROTEIN ENGINEERING MARKET, BY PRODUCT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product

    • 4.2. Instruments

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Reagents

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Services Software

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

  • CHAPTER 5: PROTEIN ENGINEERING MARKET, BY TECHNOLOGY

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Technology

    • 5.2. Rational Protein Design

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Irrational Protein Design

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

  • CHAPTER 6: PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Protein Type

    • 6.2. Monoclonal Antibodies

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Insulin

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Erythropoietin

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

    • 6.5. Interferon

      • 6.5.1. Key Market Trends, Growth Factors and Opportunities

      • 6.5.2. Market Size and Forecast, By Region

      • 6.5.3. Market Share Analysis, By Country

    • 6.6. Colony Stimulating Factor

      • 6.6.1. Key Market Trends, Growth Factors and Opportunities

      • 6.6.2. Market Size and Forecast, By Region

      • 6.6.3. Market Share Analysis, By Country

    • 6.7. Growth Hormones

      • 6.7.1. Key Market Trends, Growth Factors and Opportunities

      • 6.7.2. Market Size and Forecast, By Region

      • 6.7.3. Market Share Analysis, By Country

    • 6.8. Coagulation Factor

      • 6.8.1. Key Market Trends, Growth Factors and Opportunities

      • 6.8.2. Market Size and Forecast, By Region

      • 6.8.3. Market Share Analysis, By Country

    • 6.9. Vaccines

      • 6.9.1. Key Market Trends, Growth Factors and Opportunities

      • 6.9.2. Market Size and Forecast, By Region

      • 6.9.3. Market Share Analysis, By Country

    • 6.10. Others

      • 6.10.1. Key Market Trends, Growth Factors and Opportunities

      • 6.10.2. Market Size and Forecast, By Region

      • 6.10.3. Market Share Analysis, By Country

  • CHAPTER 7: PROTEIN ENGINEERING MARKET, BY END USER

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By End User

    • 7.2. Academic Research Institutes

      • 7.2.1. Key Market Trends, Growth Factors and Opportunities

      • 7.2.2. Market Size and Forecast, By Region

      • 7.2.3. Market Share Analysis, By Country

    • 7.3. Pharmaceutical Biotechnology Companies

      • 7.3.1. Key Market Trends, Growth Factors and Opportunities

      • 7.3.2. Market Size and Forecast, By Region

      • 7.3.3. Market Share Analysis, By Country

    • 7.4. Contract Research Organizations

      • 7.4.1. Key Market Trends, Growth Factors and Opportunities

      • 7.4.2. Market Size and Forecast, By Region

      • 7.4.3. Market Share Analysis, By Country

  • CHAPTER 8: PROTEIN ENGINEERING MARKET, BY REGION

    • 8.1. Market Overview

      • 8.1.1 Market Size and Forecast, By Region

    • 8.2. North America

      • 8.2.1. Key Market Trends and Opportunities

      • 8.2.2. Market Size and Forecast, By Product

      • 8.2.3. Market Size and Forecast, By Technology

      • 8.2.4. Market Size and Forecast, By Protein Type

      • 8.2.5. Market Size and Forecast, By End User

      • 8.2.6. Market Size and Forecast, By Country

      • 8.2.7. U.S. Protein Engineering Market

        • 8.2.7.1. Market Size and Forecast, By Product
        • 8.2.7.2. Market Size and Forecast, By Technology
        • 8.2.7.3. Market Size and Forecast, By Protein Type
        • 8.2.7.4. Market Size and Forecast, By End User

      • 8.2.8. Canada Protein Engineering Market

        • 8.2.8.1. Market Size and Forecast, By Product
        • 8.2.8.2. Market Size and Forecast, By Technology
        • 8.2.8.3. Market Size and Forecast, By Protein Type
        • 8.2.8.4. Market Size and Forecast, By End User

      • 8.2.9. Mexico Protein Engineering Market

        • 8.2.9.1. Market Size and Forecast, By Product
        • 8.2.9.2. Market Size and Forecast, By Technology
        • 8.2.9.3. Market Size and Forecast, By Protein Type
        • 8.2.9.4. Market Size and Forecast, By End User

    • 8.3. Europe

      • 8.3.1. Key Market Trends and Opportunities

      • 8.3.2. Market Size and Forecast, By Product

      • 8.3.3. Market Size and Forecast, By Technology

      • 8.3.4. Market Size and Forecast, By Protein Type

      • 8.3.5. Market Size and Forecast, By End User

      • 8.3.6. Market Size and Forecast, By Country

      • 8.3.7. France Protein Engineering Market

        • 8.3.7.1. Market Size and Forecast, By Product
        • 8.3.7.2. Market Size and Forecast, By Technology
        • 8.3.7.3. Market Size and Forecast, By Protein Type
        • 8.3.7.4. Market Size and Forecast, By End User

      • 8.3.8. Germany Protein Engineering Market

        • 8.3.8.1. Market Size and Forecast, By Product
        • 8.3.8.2. Market Size and Forecast, By Technology
        • 8.3.8.3. Market Size and Forecast, By Protein Type
        • 8.3.8.4. Market Size and Forecast, By End User

      • 8.3.9. Italy Protein Engineering Market

        • 8.3.9.1. Market Size and Forecast, By Product
        • 8.3.9.2. Market Size and Forecast, By Technology
        • 8.3.9.3. Market Size and Forecast, By Protein Type
        • 8.3.9.4. Market Size and Forecast, By End User

      • 8.3.10. Spain Protein Engineering Market

        • 8.3.10.1. Market Size and Forecast, By Product
        • 8.3.10.2. Market Size and Forecast, By Technology
        • 8.3.10.3. Market Size and Forecast, By Protein Type
        • 8.3.10.4. Market Size and Forecast, By End User

      • 8.3.11. UK Protein Engineering Market

        • 8.3.11.1. Market Size and Forecast, By Product
        • 8.3.11.2. Market Size and Forecast, By Technology
        • 8.3.11.3. Market Size and Forecast, By Protein Type
        • 8.3.11.4. Market Size and Forecast, By End User

      • 8.3.12. Russia Protein Engineering Market

        • 8.3.12.1. Market Size and Forecast, By Product
        • 8.3.12.2. Market Size and Forecast, By Technology
        • 8.3.12.3. Market Size and Forecast, By Protein Type
        • 8.3.12.4. Market Size and Forecast, By End User

      • 8.3.13. Rest Of Europe Protein Engineering Market

        • 8.3.13.1. Market Size and Forecast, By Product
        • 8.3.13.2. Market Size and Forecast, By Technology
        • 8.3.13.3. Market Size and Forecast, By Protein Type
        • 8.3.13.4. Market Size and Forecast, By End User

    • 8.4. Asia-Pacific

      • 8.4.1. Key Market Trends and Opportunities

      • 8.4.2. Market Size and Forecast, By Product

      • 8.4.3. Market Size and Forecast, By Technology

      • 8.4.4. Market Size and Forecast, By Protein Type

      • 8.4.5. Market Size and Forecast, By End User

      • 8.4.6. Market Size and Forecast, By Country

      • 8.4.7. China Protein Engineering Market

        • 8.4.7.1. Market Size and Forecast, By Product
        • 8.4.7.2. Market Size and Forecast, By Technology
        • 8.4.7.3. Market Size and Forecast, By Protein Type
        • 8.4.7.4. Market Size and Forecast, By End User

      • 8.4.8. Japan Protein Engineering Market

        • 8.4.8.1. Market Size and Forecast, By Product
        • 8.4.8.2. Market Size and Forecast, By Technology
        • 8.4.8.3. Market Size and Forecast, By Protein Type
        • 8.4.8.4. Market Size and Forecast, By End User

      • 8.4.9. India Protein Engineering Market

        • 8.4.9.1. Market Size and Forecast, By Product
        • 8.4.9.2. Market Size and Forecast, By Technology
        • 8.4.9.3. Market Size and Forecast, By Protein Type
        • 8.4.9.4. Market Size and Forecast, By End User

      • 8.4.10. South Korea Protein Engineering Market

        • 8.4.10.1. Market Size and Forecast, By Product
        • 8.4.10.2. Market Size and Forecast, By Technology
        • 8.4.10.3. Market Size and Forecast, By Protein Type
        • 8.4.10.4. Market Size and Forecast, By End User

      • 8.4.11. Australia Protein Engineering Market

        • 8.4.11.1. Market Size and Forecast, By Product
        • 8.4.11.2. Market Size and Forecast, By Technology
        • 8.4.11.3. Market Size and Forecast, By Protein Type
        • 8.4.11.4. Market Size and Forecast, By End User

      • 8.4.12. Thailand Protein Engineering Market

        • 8.4.12.1. Market Size and Forecast, By Product
        • 8.4.12.2. Market Size and Forecast, By Technology
        • 8.4.12.3. Market Size and Forecast, By Protein Type
        • 8.4.12.4. Market Size and Forecast, By End User

      • 8.4.13. Malaysia Protein Engineering Market

        • 8.4.13.1. Market Size and Forecast, By Product
        • 8.4.13.2. Market Size and Forecast, By Technology
        • 8.4.13.3. Market Size and Forecast, By Protein Type
        • 8.4.13.4. Market Size and Forecast, By End User

      • 8.4.14. Indonesia Protein Engineering Market

        • 8.4.14.1. Market Size and Forecast, By Product
        • 8.4.14.2. Market Size and Forecast, By Technology
        • 8.4.14.3. Market Size and Forecast, By Protein Type
        • 8.4.14.4. Market Size and Forecast, By End User

      • 8.4.15. Rest of Asia Pacific Protein Engineering Market

        • 8.4.15.1. Market Size and Forecast, By Product
        • 8.4.15.2. Market Size and Forecast, By Technology
        • 8.4.15.3. Market Size and Forecast, By Protein Type
        • 8.4.15.4. Market Size and Forecast, By End User

    • 8.5. LAMEA

      • 8.5.1. Key Market Trends and Opportunities

      • 8.5.2. Market Size and Forecast, By Product

      • 8.5.3. Market Size and Forecast, By Technology

      • 8.5.4. Market Size and Forecast, By Protein Type

      • 8.5.5. Market Size and Forecast, By End User

      • 8.5.6. Market Size and Forecast, By Country

      • 8.5.7. Brazil Protein Engineering Market

        • 8.5.7.1. Market Size and Forecast, By Product
        • 8.5.7.2. Market Size and Forecast, By Technology
        • 8.5.7.3. Market Size and Forecast, By Protein Type
        • 8.5.7.4. Market Size and Forecast, By End User

      • 8.5.8. South Africa Protein Engineering Market

        • 8.5.8.1. Market Size and Forecast, By Product
        • 8.5.8.2. Market Size and Forecast, By Technology
        • 8.5.8.3. Market Size and Forecast, By Protein Type
        • 8.5.8.4. Market Size and Forecast, By End User

      • 8.5.9. Saudi Arabia Protein Engineering Market

        • 8.5.9.1. Market Size and Forecast, By Product
        • 8.5.9.2. Market Size and Forecast, By Technology
        • 8.5.9.3. Market Size and Forecast, By Protein Type
        • 8.5.9.4. Market Size and Forecast, By End User

      • 8.5.10. UAE Protein Engineering Market

        • 8.5.10.1. Market Size and Forecast, By Product
        • 8.5.10.2. Market Size and Forecast, By Technology
        • 8.5.10.3. Market Size and Forecast, By Protein Type
        • 8.5.10.4. Market Size and Forecast, By End User

      • 8.5.11. Argentina Protein Engineering Market

        • 8.5.11.1. Market Size and Forecast, By Product
        • 8.5.11.2. Market Size and Forecast, By Technology
        • 8.5.11.3. Market Size and Forecast, By Protein Type
        • 8.5.11.4. Market Size and Forecast, By End User

      • 8.5.12. Rest of LAMEA Protein Engineering Market

        • 8.5.12.1. Market Size and Forecast, By Product
        • 8.5.12.2. Market Size and Forecast, By Technology
        • 8.5.12.3. Market Size and Forecast, By Protein Type
        • 8.5.12.4. Market Size and Forecast, By End User

  • CHAPTER 9: COMPETITIVE LANDSCAPE

    • 9.1. Introduction

    • 9.2. Top Winning Strategies

    • 9.3. Product Mapping Of Top 10 Player

    • 9.4. Competitive Dashboard

    • 9.5. Competitive Heatmap

    • 9.6. Top Player Positioning,2022

  • CHAPTER 10: COMPANY PROFILES

    • 10.1. Agilent Technologies, Inc.

      • 10.1.1. Company Overview

      • 10.1.2. Key Executives

      • 10.1.3. Company Snapshot

      • 10.1.4. Operating Business Segments

      • 10.1.5. Product Portfolio

      • 10.1.6. Business Performance

      • 10.1.7. Key Strategic Moves and Developments

    • 10.2. Bio-Rad Laboratories, Inc.

      • 10.2.1. Company Overview

      • 10.2.2. Key Executives

      • 10.2.3. Company Snapshot

      • 10.2.4. Operating Business Segments

      • 10.2.5. Product Portfolio

      • 10.2.6. Business Performance

      • 10.2.7. Key Strategic Moves and Developments

    • 10.3. Bruker Corporation

      • 10.3.1. Company Overview

      • 10.3.2. Key Executives

      • 10.3.3. Company Snapshot

      • 10.3.4. Operating Business Segments

      • 10.3.5. Product Portfolio

      • 10.3.6. Business Performance

      • 10.3.7. Key Strategic Moves and Developments

    • 10.4. Danaher Corporation

      • 10.4.1. Company Overview

      • 10.4.2. Key Executives

      • 10.4.3. Company Snapshot

      • 10.4.4. Operating Business Segments

      • 10.4.5. Product Portfolio

      • 10.4.6. Business Performance

      • 10.4.7. Key Strategic Moves and Developments

    • 10.5. General Electric

      • 10.5.1. Company Overview

      • 10.5.2. Key Executives

      • 10.5.3. Company Snapshot

      • 10.5.4. Operating Business Segments

      • 10.5.5. Product Portfolio

      • 10.5.6. Business Performance

      • 10.5.7. Key Strategic Moves and Developments

    • 10.6. Perkinelmer, Inc.

      • 10.6.1. Company Overview

      • 10.6.2. Key Executives

      • 10.6.3. Company Snapshot

      • 10.6.4. Operating Business Segments

      • 10.6.5. Product Portfolio

      • 10.6.6. Business Performance

      • 10.6.7. Key Strategic Moves and Developments

    • 10.7. Genscripts USA, Inc.

      • 10.7.1. Company Overview

      • 10.7.2. Key Executives

      • 10.7.3. Company Snapshot

      • 10.7.4. Operating Business Segments

      • 10.7.5. Product Portfolio

      • 10.7.6. Business Performance

      • 10.7.7. Key Strategic Moves and Developments

    • 10.8. Sigma-Aldrich Corporation

      • 10.8.1. Company Overview

      • 10.8.2. Key Executives

      • 10.8.3. Company Snapshot

      • 10.8.4. Operating Business Segments

      • 10.8.5. Product Portfolio

      • 10.8.6. Business Performance

      • 10.8.7. Key Strategic Moves and Developments

    • 10.9. Thermo Fisher Scientific

      • 10.9.1. Company Overview

      • 10.9.2. Key Executives

      • 10.9.3. Company Snapshot

      • 10.9.4. Operating Business Segments

      • 10.9.5. Product Portfolio

      • 10.9.6. Business Performance

      • 10.9.7. Key Strategic Moves and Developments

    • 10.10. Waters Corporation

      • 10.10.1. Company Overview

      • 10.10.2. Key Executives

      • 10.10.3. Company Snapshot

      • 10.10.4. Operating Business Segments

      • 10.10.5. Product Portfolio

      • 10.10.6. Business Performance

      • 10.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL PROTEIN ENGINEERING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL PROTEIN ENGINEERING MARKET FOR INSTRUMENTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL PROTEIN ENGINEERING MARKET FOR REAGENTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL PROTEIN ENGINEERING MARKET FOR SERVICES SOFTWARE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL PROTEIN ENGINEERING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL PROTEIN ENGINEERING MARKET FOR RATIONAL PROTEIN DESIGN, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL PROTEIN ENGINEERING MARKET FOR IRRATIONAL PROTEIN DESIGN, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL PROTEIN ENGINEERING MARKET FOR MONOCLONAL ANTIBODIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL PROTEIN ENGINEERING MARKET FOR INSULIN, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL PROTEIN ENGINEERING MARKET FOR ERYTHROPOIETIN, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL PROTEIN ENGINEERING MARKET FOR INTERFERON, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. GLOBAL PROTEIN ENGINEERING MARKET FOR COLONY STIMULATING FACTOR, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. GLOBAL PROTEIN ENGINEERING MARKET FOR GROWTH HORMONES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. GLOBAL PROTEIN ENGINEERING MARKET FOR COAGULATION FACTOR, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. GLOBAL PROTEIN ENGINEERING MARKET FOR VACCINES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 17. GLOBAL PROTEIN ENGINEERING MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 18. GLOBAL PROTEIN ENGINEERING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 19. GLOBAL PROTEIN ENGINEERING MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 20. GLOBAL PROTEIN ENGINEERING MARKET FOR PHARMACEUTICAL BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 21. GLOBAL PROTEIN ENGINEERING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 22. GLOBAL PROTEIN ENGINEERING MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 23. NORTH AMERICA PROTEIN ENGINEERING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 24. NORTH AMERICA PROTEIN ENGINEERING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 25. NORTH AMERICA PROTEIN ENGINEERING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 26. NORTH AMERICA PROTEIN ENGINEERING, BY PROTEIN TYPE, 2022-2032 ($MILLION)
  • TABLE 27. NORTH AMERICA PROTEIN ENGINEERING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 28. U.S. PROTEIN ENGINEERING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 29. U.S. PROTEIN ENGINEERING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 30. U.S. PROTEIN ENGINEERING, BY PROTEIN TYPE, 2022-2032 ($MILLION)
  • TABLE 31. U.S. PROTEIN ENGINEERING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 32. CANADA PROTEIN ENGINEERING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 33. CANADA PROTEIN ENGINEERING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 34. CANADA PROTEIN ENGINEERING, BY PROTEIN TYPE, 2022-2032 ($MILLION)
  • TABLE 35. CANADA PROTEIN ENGINEERING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 36. MEXICO PROTEIN ENGINEERING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 37. MEXICO PROTEIN ENGINEERING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 38. MEXICO PROTEIN ENGINEERING, BY PROTEIN TYPE, 2022-2032 ($MILLION)
  • TABLE 39. MEXICO PROTEIN ENGINEERING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 40. EUROPE PROTEIN ENGINEERING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 41. EUROPE PROTEIN ENGINEERING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 42. EUROPE PROTEIN ENGINEERING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 43. EUROPE PROTEIN ENGINEERING, BY PROTEIN TYPE, 2022-2032 ($MILLION)
  • TABLE 44. EUROPE PROTEIN ENGINEERING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 45. FRANCE PROTEIN ENGINEERING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 46. FRANCE PROTEIN ENGINEERING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 47. FRANCE PROTEIN ENGINEERING, BY PROTEIN TYPE, 2022-2032 ($MILLION)
  • TABLE 48. FRANCE PROTEIN ENGINEERING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 49. GERMANY PROTEIN ENGINEERING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 50. GERMANY PROTEIN ENGINEERING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 51. GERMANY PROTEIN ENGINEERING, BY PROTEIN TYPE, 2022-2032 ($MILLION)
  • TABLE 52. GERMANY PROTEIN ENGINEERING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 53. ITALY PROTEIN ENGINEERING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 54. ITALY PROTEIN ENGINEERING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 55. ITALY PROTEIN ENGINEERING, BY PROTEIN TYPE, 2022-2032 ($MILLION)
  • TABLE 56. ITALY PROTEIN ENGINEERING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 57. SPAIN PROTEIN ENGINEERING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 58. SPAIN PROTEIN ENGINEERING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 59. SPAIN PROTEIN ENGINEERING, BY PROTEIN TYPE, 2022-2032 ($MILLION)
  • TABLE 60. SPAIN PROTEIN ENGINEERING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 61. UK PROTEIN ENGINEERING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 62. UK PROTEIN ENGINEERING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 63. UK PROTEIN ENGINEERING, BY PROTEIN TYPE, 2022-2032 ($MILLION)
  • TABLE 64. UK PROTEIN ENGINEERING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 65. RUSSIA PROTEIN ENGINEERING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 66. RUSSIA PROTEIN ENGINEERING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 67. RUSSIA PROTEIN ENGINEERING, BY PROTEIN TYPE, 2022-2032 ($MILLION)
  • TABLE 68. RUSSIA PROTEIN ENGINEERING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 69. REST OF EUROPE PROTEIN ENGINEERING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 70. REST OF EUROPE PROTEIN ENGINEERING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 71. REST OF EUROPE PROTEIN ENGINEERING, BY PROTEIN TYPE, 2022-2032 ($MILLION)
  • TABLE 72. REST OF EUROPE PROTEIN ENGINEERING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 73. ASIA-PACIFIC PROTEIN ENGINEERING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 74. ASIA-PACIFIC PROTEIN ENGINEERING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 75. ASIA-PACIFIC PROTEIN ENGINEERING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 76. ASIA-PACIFIC PROTEIN ENGINEERING, BY PROTEIN TYPE, 2022-2032 ($MILLION)
  • TABLE 77. ASIA-PACIFIC PROTEIN ENGINEERING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 78. CHINA PROTEIN ENGINEERING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 79. CHINA PROTEIN ENGINEERING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 80. CHINA PROTEIN ENGINEERING, BY PROTEIN TYPE, 2022-2032 ($MILLION)
  • TABLE 81. CHINA PROTEIN ENGINEERING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 82. JAPAN PROTEIN ENGINEERING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 83. JAPAN PROTEIN ENGINEERING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 84. JAPAN PROTEIN ENGINEERING, BY PROTEIN TYPE, 2022-2032 ($MILLION)
  • TABLE 85. JAPAN PROTEIN ENGINEERING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 86. INDIA PROTEIN ENGINEERING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 87. INDIA PROTEIN ENGINEERING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 88. INDIA PROTEIN ENGINEERING, BY PROTEIN TYPE, 2022-2032 ($MILLION)
  • TABLE 89. INDIA PROTEIN ENGINEERING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 90. SOUTH KOREA PROTEIN ENGINEERING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 91. SOUTH KOREA PROTEIN ENGINEERING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 92. SOUTH KOREA PROTEIN ENGINEERING, BY PROTEIN TYPE, 2022-2032 ($MILLION)
  • TABLE 93. SOUTH KOREA PROTEIN ENGINEERING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 94. AUSTRALIA PROTEIN ENGINEERING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 95. AUSTRALIA PROTEIN ENGINEERING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 96. AUSTRALIA PROTEIN ENGINEERING, BY PROTEIN TYPE, 2022-2032 ($MILLION)
  • TABLE 97. AUSTRALIA PROTEIN ENGINEERING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 98. THAILAND PROTEIN ENGINEERING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 99. THAILAND PROTEIN ENGINEERING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 100. THAILAND PROTEIN ENGINEERING, BY PROTEIN TYPE, 2022-2032 ($MILLION)
  • TABLE 101. THAILAND PROTEIN ENGINEERING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 102. MALAYSIA PROTEIN ENGINEERING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 103. MALAYSIA PROTEIN ENGINEERING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 104. MALAYSIA PROTEIN ENGINEERING, BY PROTEIN TYPE, 2022-2032 ($MILLION)
  • TABLE 105. MALAYSIA PROTEIN ENGINEERING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 106. INDONESIA PROTEIN ENGINEERING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 107. INDONESIA PROTEIN ENGINEERING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 108. INDONESIA PROTEIN ENGINEERING, BY PROTEIN TYPE, 2022-2032 ($MILLION)
  • TABLE 109. INDONESIA PROTEIN ENGINEERING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 110. REST OF ASIA PACIFIC PROTEIN ENGINEERING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 111. REST OF ASIA PACIFIC PROTEIN ENGINEERING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 112. REST OF ASIA PACIFIC PROTEIN ENGINEERING, BY PROTEIN TYPE, 2022-2032 ($MILLION)
  • TABLE 113. REST OF ASIA PACIFIC PROTEIN ENGINEERING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 114. LAMEA PROTEIN ENGINEERING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 115. LAMEA PROTEIN ENGINEERING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 116. LAMEA PROTEIN ENGINEERING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 117. LAMEA PROTEIN ENGINEERING, BY PROTEIN TYPE, 2022-2032 ($MILLION)
  • TABLE 118. LAMEA PROTEIN ENGINEERING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 119. BRAZIL PROTEIN ENGINEERING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 120. BRAZIL PROTEIN ENGINEERING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 121. BRAZIL PROTEIN ENGINEERING, BY PROTEIN TYPE, 2022-2032 ($MILLION)
  • TABLE 122. BRAZIL PROTEIN ENGINEERING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 123. SOUTH AFRICA PROTEIN ENGINEERING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 124. SOUTH AFRICA PROTEIN ENGINEERING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 125. SOUTH AFRICA PROTEIN ENGINEERING, BY PROTEIN TYPE, 2022-2032 ($MILLION)
  • TABLE 126. SOUTH AFRICA PROTEIN ENGINEERING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 127. SAUDI ARABIA PROTEIN ENGINEERING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 128. SAUDI ARABIA PROTEIN ENGINEERING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 129. SAUDI ARABIA PROTEIN ENGINEERING, BY PROTEIN TYPE, 2022-2032 ($MILLION)
  • TABLE 130. SAUDI ARABIA PROTEIN ENGINEERING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 131. UAE PROTEIN ENGINEERING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 132. UAE PROTEIN ENGINEERING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 133. UAE PROTEIN ENGINEERING, BY PROTEIN TYPE, 2022-2032 ($MILLION)
  • TABLE 134. UAE PROTEIN ENGINEERING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 135. ARGENTINA PROTEIN ENGINEERING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 136. ARGENTINA PROTEIN ENGINEERING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 137. ARGENTINA PROTEIN ENGINEERING, BY PROTEIN TYPE, 2022-2032 ($MILLION)
  • TABLE 138. ARGENTINA PROTEIN ENGINEERING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 139. REST OF LAMEA PROTEIN ENGINEERING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 140. REST OF LAMEA PROTEIN ENGINEERING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 141. REST OF LAMEA PROTEIN ENGINEERING, BY PROTEIN TYPE, 2022-2032 ($MILLION)
  • TABLE 142. REST OF LAMEA PROTEIN ENGINEERING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 143. AGILENT TECHNOLOGIES, INC.: KEY EXECUTIVES
  • TABLE 144. AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
  • TABLE 145. AGILENT TECHNOLOGIES, INC.: OPERATING SEGMENTS
  • TABLE 146. AGILENT TECHNOLOGIES, INC.: PRODUCT PORTFOLIO
  • TABLE 147. AGILENT TECHNOLOGIES, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 148. BIO-RAD LABORATORIES, INC.: KEY EXECUTIVES
  • TABLE 149. BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
  • TABLE 150. BIO-RAD LABORATORIES, INC.: OPERATING SEGMENTS
  • TABLE 151. BIO-RAD LABORATORIES, INC.: PRODUCT PORTFOLIO
  • TABLE 152. BIO-RAD LABORATORIES, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 153. BRUKER CORPORATION: KEY EXECUTIVES
  • TABLE 154. BRUKER CORPORATION: COMPANY SNAPSHOT
  • TABLE 155. BRUKER CORPORATION: OPERATING SEGMENTS
  • TABLE 156. BRUKER CORPORATION: PRODUCT PORTFOLIO
  • TABLE 157. BRUKER CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 158. DANAHER CORPORATION: KEY EXECUTIVES
  • TABLE 159. DANAHER CORPORATION: COMPANY SNAPSHOT
  • TABLE 160. DANAHER CORPORATION: OPERATING SEGMENTS
  • TABLE 161. DANAHER CORPORATION: PRODUCT PORTFOLIO
  • TABLE 162. DANAHER CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 163. GENERAL ELECTRIC: KEY EXECUTIVES
  • TABLE 164. GENERAL ELECTRIC: COMPANY SNAPSHOT
  • TABLE 165. GENERAL ELECTRIC: OPERATING SEGMENTS
  • TABLE 166. GENERAL ELECTRIC: PRODUCT PORTFOLIO
  • TABLE 167. GENERAL ELECTRIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 168. PERKINELMER, INC.: KEY EXECUTIVES
  • TABLE 169. PERKINELMER, INC.: COMPANY SNAPSHOT
  • TABLE 170. PERKINELMER, INC.: OPERATING SEGMENTS
  • TABLE 171. PERKINELMER, INC.: PRODUCT PORTFOLIO
  • TABLE 172. PERKINELMER, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 173. GENSCRIPTS USA, INC.: KEY EXECUTIVES
  • TABLE 174. GENSCRIPTS USA, INC.: COMPANY SNAPSHOT
  • TABLE 175. GENSCRIPTS USA, INC.: OPERATING SEGMENTS
  • TABLE 176. GENSCRIPTS USA, INC.: PRODUCT PORTFOLIO
  • TABLE 177. GENSCRIPTS USA, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 178. SIGMA-ALDRICH CORPORATION: KEY EXECUTIVES
  • TABLE 179. SIGMA-ALDRICH CORPORATION: COMPANY SNAPSHOT
  • TABLE 180. SIGMA-ALDRICH CORPORATION: OPERATING SEGMENTS
  • TABLE 181. SIGMA-ALDRICH CORPORATION: PRODUCT PORTFOLIO
  • TABLE 182. SIGMA-ALDRICH CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 183. THERMO FISHER SCIENTIFIC: KEY EXECUTIVES
  • TABLE 184. THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
  • TABLE 185. THERMO FISHER SCIENTIFIC: OPERATING SEGMENTS
  • TABLE 186. THERMO FISHER SCIENTIFIC: PRODUCT PORTFOLIO
  • TABLE 187. THERMO FISHER SCIENTIFIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 188. WATERS CORPORATION: KEY EXECUTIVES
  • TABLE 189. WATERS CORPORATION: COMPANY SNAPSHOT
  • TABLE 190. WATERS CORPORATION: OPERATING SEGMENTS
  • TABLE 191. WATERS CORPORATION: PRODUCT PORTFOLIO
  • TABLE 192. WATERS CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL PROTEIN ENGINEERING MARKET SEGMENTATION
  • FIGURE 2. GLOBAL PROTEIN ENGINEERING MARKET
  • FIGURE 3. SEGMENTATION PROTEIN ENGINEERING MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN PROTEIN ENGINEERING MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALPROTEIN ENGINEERING MARKET
  • FIGURE 11. PROTEIN ENGINEERING MARKET SEGMENTATION, BY BY PRODUCT
  • FIGURE 12. PROTEIN ENGINEERING MARKET FOR INSTRUMENTS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. PROTEIN ENGINEERING MARKET FOR REAGENTS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. PROTEIN ENGINEERING MARKET FOR SERVICES SOFTWARE, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 15. PROTEIN ENGINEERING MARKET SEGMENTATION, BY BY TECHNOLOGY
  • FIGURE 16. PROTEIN ENGINEERING MARKET FOR RATIONAL PROTEIN DESIGN, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. PROTEIN ENGINEERING MARKET FOR IRRATIONAL PROTEIN DESIGN, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. PROTEIN ENGINEERING MARKET SEGMENTATION, BY BY PROTEIN TYPE
  • FIGURE 19. PROTEIN ENGINEERING MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 20. PROTEIN ENGINEERING MARKET FOR INSULIN, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 21. PROTEIN ENGINEERING MARKET FOR ERYTHROPOIETIN, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 22. PROTEIN ENGINEERING MARKET FOR INTERFERON, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 23. PROTEIN ENGINEERING MARKET FOR COLONY STIMULATING FACTOR, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 24. PROTEIN ENGINEERING MARKET FOR GROWTH HORMONES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 25. PROTEIN ENGINEERING MARKET FOR COAGULATION FACTOR, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 26. PROTEIN ENGINEERING MARKET FOR VACCINES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 27. PROTEIN ENGINEERING MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 28. PROTEIN ENGINEERING MARKET SEGMENTATION, BY BY END USER
  • FIGURE 29. PROTEIN ENGINEERING MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 30. PROTEIN ENGINEERING MARKET FOR PHARMACEUTICAL BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 31. PROTEIN ENGINEERING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 32. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 33. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 34. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 35. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 36. COMPETITIVE DASHBOARD
  • FIGURE 37. COMPETITIVE HEATMAP: PROTEIN ENGINEERING MARKET
  • FIGURE 38. Top player positioning, 2022
  • FIGURE 39. AGILENT TECHNOLOGIES, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 40. AGILENT TECHNOLOGIES, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 41. AGILENT TECHNOLOGIES, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 42. BIO-RAD LABORATORIES, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 43. BIO-RAD LABORATORIES, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 44. BIO-RAD LABORATORIES, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 45. BRUKER CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 46. BRUKER CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 47. BRUKER CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 48. DANAHER CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 49. DANAHER CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 50. DANAHER CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 51. GENERAL ELECTRIC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 52. GENERAL ELECTRIC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 53. GENERAL ELECTRIC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 54. PERKINELMER, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 55. PERKINELMER, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 56. PERKINELMER, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 57. GENSCRIPTS USA, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 58. GENSCRIPTS USA, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 59. GENSCRIPTS USA, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 60. SIGMA-ALDRICH CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 61. SIGMA-ALDRICH CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 62. SIGMA-ALDRICH CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 63. THERMO FISHER SCIENTIFIC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 64. THERMO FISHER SCIENTIFIC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 65. THERMO FISHER SCIENTIFIC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 66. WATERS CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 67. WATERS CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 68. WATERS CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Protein Engineering Market

Start reading.
This Report and over 66,944+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,930
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers